Understanding Selenium and Glutathione as Antiviral Factors in COVID-19: Does the Viral Mpro Protease Target Host Selenoproteins and Glutathione Synthesis?
Abstract:Glutathione peroxidases (GPX), a family of antioxidant selenoenzymes, functionally link selenium and glutathione, which both show correlations with clinical outcomes in COVID-19. Thus, it is highly significant that cytosolic GPX1 has been shown to interact with an inactive C145A mutant of M
pro
, the main cysteine protease of SARS-CoV-2, but not with catalytically active wild-type M
pro
. This seemingly anomalous result is what might be expected if GPX1 is a substr… Show more
“…The relatively higher accessibilities of cleavage sites are in agreement with the susceptibilities of CTBP1 and IRAK1 for proteolysis in vitro ( Figure 5 ) and indicate that probabilities of cleavage sites predicted by the NetCorona webserver need to be interpreted by considering surface accessibilities of putative sites, as well. Our result highlights that determination of apparent accessibilities of cleavage sites in the protein structures is not sufficient enough ( Figure 2 ); in agreement with the results of Taylor and Radding [ 29 ], we also suggest the detailed determination of structural characteristics, especially the calculation of numerical SASA values ( Figure 7 ) for more reliable cleavage site prediction.…”
Section: Resultssupporting
confidence: 89%
“…Additionally, we assumed that structural contexts of the putative cleavage sites need to be considered, therefore, accessibilities of target regions were also determined. A similar in silico approach has already been applied for the identification of potential cleavage sites in host selenoproteins and enzymes of glutathione synthesis [ 29 ], but neither proteomic [ 21 ] nor specifically targeted analyses proved cleavages of these targets in vitro to date. Interestingly, PAI2 was identified as a substrate of SARS-CoV and hCoV-NL63 3CLpro, as well, while cleavage of PLMN was not detected by a proteomic analysis [ 21 ].…”
Section: Resultsmentioning
confidence: 99%
“…This algorithm was applied previously to predict cleavage sites in the nucleocapsid protein of porcine epidemic diarrhea virus (PEDV) 3CLpro [ 27 ], in the equine coronavirus polyprotein [ 28 ], or in human protein targets of SARS-CoV 3CLpro while developing the method [ 26 ]. In the case of SARS-CoV-2 3CLpro, glutathione peroxidase 1, selenoprotein F, and thioredoxin reductase 1 were proposed to be host substrates by using in silico algorithms [ 29 ], but the results were not validated in vitro. These proteins were not identified in the recently reported proteomic analysis as substrates of SARS-CoV-2 3CLpro [ 21 ], although, in vitro identification of host targets in additional cell types remain to be performed.…”
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease-19 (COVID-19) being associated with severe pneumonia. Like with other viruses, the interaction of SARS-CoV-2 with host cell proteins is necessary for successful replication, and cleavage of cellular targets by the viral protease also may contribute to the pathogenesis, but knowledge about the human proteins that are processed by the main protease (3CLpro) of SARS-CoV-2 is still limited. We tested the prediction potentials of two different in silico methods for the identification of SARS-CoV-2 3CLpro cleavage sites in human proteins. Short stretches of homologous host-pathogen protein sequences (SSHHPS) that are present in SARS-CoV-2 polyprotein and human proteins were identified using BLAST analysis, and the NetCorona 1.0 webserver was used to successfully predict cleavage sites, although this method was primarily developed for SARS-CoV. Human C-terminal-binding protein 1 (CTBP1) was found to be cleaved in vitro by SARS-CoV-2 3CLpro, the existence of the cleavage site was proved experimentally by using a His6-MBP-mEYFP recombinant substrate containing the predicted target sequence. Our results highlight both potentials and limitations of the tested algorithms. The identification of candidate host substrates of 3CLpro may help better develop an understanding of the molecular mechanisms behind the replication and pathogenesis of SARS-CoV-2.
“…The relatively higher accessibilities of cleavage sites are in agreement with the susceptibilities of CTBP1 and IRAK1 for proteolysis in vitro ( Figure 5 ) and indicate that probabilities of cleavage sites predicted by the NetCorona webserver need to be interpreted by considering surface accessibilities of putative sites, as well. Our result highlights that determination of apparent accessibilities of cleavage sites in the protein structures is not sufficient enough ( Figure 2 ); in agreement with the results of Taylor and Radding [ 29 ], we also suggest the detailed determination of structural characteristics, especially the calculation of numerical SASA values ( Figure 7 ) for more reliable cleavage site prediction.…”
Section: Resultssupporting
confidence: 89%
“…Additionally, we assumed that structural contexts of the putative cleavage sites need to be considered, therefore, accessibilities of target regions were also determined. A similar in silico approach has already been applied for the identification of potential cleavage sites in host selenoproteins and enzymes of glutathione synthesis [ 29 ], but neither proteomic [ 21 ] nor specifically targeted analyses proved cleavages of these targets in vitro to date. Interestingly, PAI2 was identified as a substrate of SARS-CoV and hCoV-NL63 3CLpro, as well, while cleavage of PLMN was not detected by a proteomic analysis [ 21 ].…”
Section: Resultsmentioning
confidence: 99%
“…This algorithm was applied previously to predict cleavage sites in the nucleocapsid protein of porcine epidemic diarrhea virus (PEDV) 3CLpro [ 27 ], in the equine coronavirus polyprotein [ 28 ], or in human protein targets of SARS-CoV 3CLpro while developing the method [ 26 ]. In the case of SARS-CoV-2 3CLpro, glutathione peroxidase 1, selenoprotein F, and thioredoxin reductase 1 were proposed to be host substrates by using in silico algorithms [ 29 ], but the results were not validated in vitro. These proteins were not identified in the recently reported proteomic analysis as substrates of SARS-CoV-2 3CLpro [ 21 ], although, in vitro identification of host targets in additional cell types remain to be performed.…”
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease-19 (COVID-19) being associated with severe pneumonia. Like with other viruses, the interaction of SARS-CoV-2 with host cell proteins is necessary for successful replication, and cleavage of cellular targets by the viral protease also may contribute to the pathogenesis, but knowledge about the human proteins that are processed by the main protease (3CLpro) of SARS-CoV-2 is still limited. We tested the prediction potentials of two different in silico methods for the identification of SARS-CoV-2 3CLpro cleavage sites in human proteins. Short stretches of homologous host-pathogen protein sequences (SSHHPS) that are present in SARS-CoV-2 polyprotein and human proteins were identified using BLAST analysis, and the NetCorona 1.0 webserver was used to successfully predict cleavage sites, although this method was primarily developed for SARS-CoV. Human C-terminal-binding protein 1 (CTBP1) was found to be cleaved in vitro by SARS-CoV-2 3CLpro, the existence of the cleavage site was proved experimentally by using a His6-MBP-mEYFP recombinant substrate containing the predicted target sequence. Our results highlight both potentials and limitations of the tested algorithms. The identification of candidate host substrates of 3CLpro may help better develop an understanding of the molecular mechanisms behind the replication and pathogenesis of SARS-CoV-2.
“…This is interesting in light of a recent report that SELENOF may be targeted for proteolysis by the SARS-CoV-2 main protease M pro , because the SELENOF protein contains a sequence (TVLQ/AVSA) that is almost identical to a known viral M pro cleavage site (TVLQ/AVGA). 16 Taken together, these observations suggest that disruption of SELENOF function may be particularly important for SARS-CoV-2 replication.…”
A significant, positive association between selenium status and COVID-19 prognosis has recently been identified. The present study investigated the influence of SARS-CoV-2 on host selenoproteins which mediate many beneficial actions of selenium. We found that SARS-CoV-2 suppressed mRNA expression of selenoproteins associated with ferroptosis (GPX4), ER stress (SELENOF, SELENOK, SELENOM and SELENOS) and DNA synthesis (TXNRD3) in Vero cells, providing a deeper insight into the connection between selenium and SARS-CoV-2.
“…Regarding selenium, Taylor and Radding ( 55 ) mentioned that the resulting collateral damage due to increased oxidative stress and inflammation would be exacerbated by dietary deficiency of selenium and GSH precursors. In the review by Hiffler and Rakotoambinina ( 39 ), it was observed that low-selenium status is common in individuals considered at risk of developing severe COVID-19, particularly in the elderly.…”
The coronavirus disease 2019 (COVID-19) pandemic has become a serious global health problem and numerous studies are currently being conducted to improve understanding of the components of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, as well as to identify solutions that mitigate the effects of COVID-19 symptoms. The nutritional supplement Vita Deyun
®
is composed of silymarin, glutathione, vitamin C and selenium. Studies of its individual components have demonstrated their benefits as anti-inflammatory agents, antioxidants and enhancers of the immune response. Therefore, the present study aimed to evaluate the
in vitro
effects of Vita Deyun on the expression of angiotensin-converting enzyme 2 (
ACE2
) in diverse cell lines, as well as in the presence or absence of the SARS-CoV-2 open reading frame (ORF)3a protein. Through reverse transcription-quantitative PCR, the use of viral particles containing SARS-CoV-2 ORF3a and bioinformatics analysis via the National Center for Biotechnology Information databases,
ACE2
was determined to be highly expressed in oral and skin epithelial cells, with a lower expression observed in lung cells. Notably, the expression of SARS-CoV-2 ORF3a increased the level of
ACE2
expression and Vita Deyun treatment diminished this effect. In addition, Vita Deyun treatment markedly decreased interleukin-18 mRNA levels. The combination of phytonutrients in Vita Deyun may help to boost the immune system and could reduce the effects of COVID-19. Ongoing clinical studies are required to provide evidence of the efficacy of Vita Deyun.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.